跳至主要内容
临床试验/CTRI/2019/08/020946
CTRI/2019/08/020946尚未招募2 期

Phase II non-randomized open clinical evaluation of Siddha Drug "Naga Chendhooram" for Madhumegam (Type 2 Diabetes Mellitus)- in patients of both gender between age group of 30 to 60 years, attending OPD at AAGHIM attached with GSMC

Government Siddha Medical College1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2019年4月9日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
20
试验地点
1
主要终点
Reduction in clinical symptoms

研究概览

简要总结

This is a Non randomised open clinical trial to study the safety and efficacy of siddha drug "Naga Chendhooram". Drug is given 100 mg twice a day for 90 days. Clinical trial is conducted after completion of preclinical toxicity studies. The said drug "Naga Chendhooram" has reference in "Siddha Formulary of india" - part1 . During the study, all the related data will be recorded and documented.

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Not Applicable

入排标准

年龄范围
30.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Mandatory Fasting blood glucose-120 to 160 mg/do PP blood glucose- 180 to 280 mg/DL HbA1c- 6.5 to 9% Optional Polyuria Polyphagia Polydipsia Nocturia.

排除标准

  • Insulin dependent Diabetes mellitus Cardiovascular disease Diabetic nephropathy Diabetic retinopathy Pregnant women Lactating mothers Tuberculosis affected individuals HbA1c > 9%.

结局指标

主要结局

Reduction in clinical symptoms

时间窗: 90 days

Reduction in blood sugar and HbA1c level by atleast 20% or to maintain HbA1c level within 7%

时间窗: 90 days

次要结局

  • Secondary outcome is assessed by comparing the safety parameters before and after treatment(90 days)

研究者

发起方
Government Siddha Medical College
申办方类型
Government medical college

研究点 (1)

Loading locations...

相似试验

Clinical trial of Siddha Drug "Naga Chendhooram" for... | 临床试验